Skip to main content

Table 3 Hemorrhagic adverse events

From: A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

Treatment

Patient

Preferred term

Severity

Possibly related to study drug

Placebo

1

Hematochezia

Mild

 
  

Gingival bleeding

Moderate

Yes

  

Hemorrhoids

Mild

 

Prasugrel

2

Menorrhagia

Moderate

Yes

 

3

Menorrhagia

Mild

Yes

  

Ecchymosis

Mild

 
 

4

Epistaxis

Mild

Yes

 

5

Contusion

Mild

Yes

 

6

Epistaxis

Mild

 
 

7

Gingival bleeding

Mild

Yes

 

8

Gingival bleeding

Mild

Yes

 

9

Hematochezia

Mild